Jackson et al. identified neovascular nAMD as a principal etiology of irreversible blindness, with their STAR trial—a randomized, double-masked, sham-controlled study—demonstrating that stereotactic radiotherapy (SRT) achieved significant reduction in anti-VEGF injection frequency without compromising best-corrected visual acuity [200]. Here, VEGFA is linked to Blindness.